Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.

[1]  P. Witt-Enderby,et al.  2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists. , 2009, Journal of medicinal chemistry.

[2]  J. Boutin,et al.  Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands. , 2008, Bioorganic & medicinal chemistry.

[3]  P. Witt-Enderby,et al.  Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands. , 2008, Bioorganic & medicinal chemistry.

[4]  M. Mor,et al.  N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands. , 2007, Journal of medicinal chemistry.

[5]  A. Tsotinis,et al.  Synthesis of compounds as melatonin agonists and antagonists. , 2007, Mini reviews in medicinal chemistry.

[6]  P. Witt-Enderby,et al.  Synthesis and pharmacological evaluation of 6a,7-dihydro-6H,13H-pyrazino[1,2-a;4,5-a′]diindole analogs as melatonin receptor ligands , 2007 .

[7]  M. Mor,et al.  Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands. , 2006, Journal of Medicinal Chemistry.

[8]  M. Mor,et al.  MT2 selective melatonin receptor antagonists: design and structure-activity relationships , 2006 .

[9]  D. Zlotos.  Recent Advances in Melatonin Receptor Ligands , 2005, Archiv der Pharmazie.

[10]  M. Mor,et al.  Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models. , 2005, Journal of medicinal chemistry.

[11]  S. Bertenshaw,et al.  Tetrahydroisoquinoline derivatives as melatonin MT2 receptor antagonists. , 2004, Bioorganic & medicinal chemistry letters.

[12]  K. Varani,et al.  Design, synthesis and preliminary pharmacological evaluation of rigid analogues of the nicotinic agonist 1,1-dimethyl-4- phenylpiperazinium iodide (DMPP) , 2004 .

[13]  E. Novellino,et al.  Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors. , 2003, Journal of medicinal chemistry.

[14]  J. Nicolas,et al.  Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands. , 2002, Journal of medicinal chemistry.

[15]  A. Tsotinis,et al.  Synthesis of new tricyclic melatoninergic ligands. , 2001, Farmaco.

[16]  K. Diker,et al.  Reductive Pictet-Spengler Cyclization of Nitriles in the Presence of Tryptamine: Synthesis of Indolo[2,3-a]quinolizidine, Nazlinine, and Elaeocarpidine , 1997 .

[17]  S. Reppert,et al.  Melatonin receptors step into the light: cloning and classification of subtypes. , 1996, Trends in pharmacological sciences.

[18]  M. Brimble,et al.  SYNTHESIS OF 2-METHYLPYRROLO[1,2-A]PYRAZIN-1(2H)-ONE , 1988 .

[19]  M. Matsui,et al.  Synthesis of Mitomycin Analogues Part I , 1972 .